Cargando…
CKS1B as Drug Resistance-Inducing Gene—A Potential Target to Improve Cancer Therapy
Cancer is a threat to human health and life. Although previously centered on chemical drug treatments, cancer treatment has entered an era of precision targeted therapy. Targeted therapy entails precise guidance, allowing the selective killing of cancer cells and thereby reducing damage to healthy t...
Autores principales: | Shi, Wenwen, Huang, Qiudi, Xie, Jiacui, Wang, He, Yu, Xiyong, Zhou, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545642/ https://www.ncbi.nlm.nih.gov/pubmed/33102238 http://dx.doi.org/10.3389/fonc.2020.582451 |
Ejemplares similares
-
pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer
por: Wang, He, et al.
Publicado: (2021) -
A redox-responsive self-assembling COA-4-arm PEG prodrug nanosystem for dual drug delivery suppresses cancer metastasis and drug resistance by downregulating hsp90 expression
por: Zhou, Yi, et al.
Publicado: (2023) -
Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis
por: Wang, He, et al.
Publicado: (2020) -
High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma
por: Yu, Kai, et al.
Publicado: (2022) -
The CKS1/CKS2 Proteostasis Axis Is Crucial to Maintain Hematopoietic Stem Cell Function
por: Grey, William, et al.
Publicado: (2023)